FDA gives thumbs down to MDMA for now, demanding further researchThe FDA has requested further study on MDMA-assisted therapy for PTSD, dealing a blow to Lykos Therapeutics and the broader psychedelics movement.
Three Studies of MDMA Treatment Retracted by Scientific JournalPsychopharmacology retracted papers on MDMA-assisted therapy due to unethical conduct at a study site.
F.D.A. Declines to Approve MDMA Therapy, Seeking More StudyFDA declined to approve MDMA-assisted therapy for PTSD due to insufficient data, requesting additional clinical trials.
FDA gives thumbs down to MDMA for now, demanding further researchThe FDA has requested further study on MDMA-assisted therapy for PTSD, dealing a blow to Lykos Therapeutics and the broader psychedelics movement.
Three Studies of MDMA Treatment Retracted by Scientific JournalPsychopharmacology retracted papers on MDMA-assisted therapy due to unethical conduct at a study site.
F.D.A. Declines to Approve MDMA Therapy, Seeking More StudyFDA declined to approve MDMA-assisted therapy for PTSD due to insufficient data, requesting additional clinical trials.
PTSD Treatments Are Falling Short for Many PatientsMDMA-assisted therapy may offer a new treatment for PTSD, especially for patients who do not respond well to traditional treatments.
Psychoactive drugs are having a moment. The FDA will soon weigh inMDMA-assisted therapy can have dramatic positive effects on those suffering from PTSD and other mental illnesses, showcasing its potential as a groundbreaking treatment option.
FDA deadline on ecstasy for PTSD prompts lobbying blitzFDA faces decision on MDMA-assisted therapy for PTSD treatment amid controversy.
Lawmakers push for more consideration into MDMA-assisted therapy for veteransVeterans are advocating for FDA approval of MDMA-assisted therapy to help with PTSD.
PTSD Treatments Are Falling Short for Many PatientsMDMA-assisted therapy may offer a new treatment for PTSD, especially for patients who do not respond well to traditional treatments.
Psychoactive drugs are having a moment. The FDA will soon weigh inMDMA-assisted therapy can have dramatic positive effects on those suffering from PTSD and other mental illnesses, showcasing its potential as a groundbreaking treatment option.
FDA deadline on ecstasy for PTSD prompts lobbying blitzFDA faces decision on MDMA-assisted therapy for PTSD treatment amid controversy.
Lawmakers push for more consideration into MDMA-assisted therapy for veteransVeterans are advocating for FDA approval of MDMA-assisted therapy to help with PTSD.
F.D.A. Panel Rejects MDMA-Aided Therapy for PTSDThe FDA advisory panel rejected MDMA-assisted therapy for PTSD due to concerns about study designs, participants' ability to guess MDMA use, and potential biases.
FDA panel votes against ecstasy for PTSDThe FDA usually follows advisory committees' advice, with a decision expected on Lykos Therapeutics' drug application by Aug. 11.
F.D.A. Panel Rejects MDMA-Aided Therapy for PTSDThe FDA advisory panel rejected MDMA-assisted therapy for PTSD due to concerns about study designs, participants' ability to guess MDMA use, and potential biases.
FDA panel votes against ecstasy for PTSDThe FDA usually follows advisory committees' advice, with a decision expected on Lykos Therapeutics' drug application by Aug. 11.
Psychedelic drugs have great therapeutic benefit if understood on their own terms | Ross Ellenhorn and Dimitri MugianisAn advisory panel rejected MDMA-assisted therapy for PTSD, impacting FDA approval of ecstasy. The rejection is viewed as a significant setback for the psychedelic movement.
The FDA Should Reject MDMA Therapy-but Not for the Reasons You ThinkFDA panel voted against approving Lykos Therapeutics' MDMA-assisted therapy for PTSD, raising concerns about safety and efficacy.